Type 1 diabetes overview

Answer generated by Itaca · 15 sources · October 17, 2026

Original question

Type 1 diabetes

Summary

Type 1 diabetes (T1D) is usually an autoimmune condition that causes severe insulin deficiency; insulin is essential for survival and must not be stopped. Care centers on individualized insulin replacement, glucose monitoring—often continuous glucose monitoring (CGM)—education, and prevention of hypoglycemia and diabetic ketoacidosis (DKA). The right regimen depends on age, pregnancy status, comorbidities, preferences, and access to technology. [1]

Diagnosis and classification

Diagnose diabetes using standard plasma-glucose or HbA1c criteria, with confirmation when required; in a person with classic symptoms or hyperglycemic crisis, urgent treatment should not be delayed for confirmatory testing. T1D is supported by islet autoantibodies and evidence of insulin deficiency, but presentation can overlap with other diabetes types. In adults with uncertain classification, clinical context, autoantibodies, and C-peptide may help; no single feature is definitive. [1]

Core management

  • Insulin: Use basal–bolus injections or continuous subcutaneous insulin infusion, individualized to meals, activity, glucose patterns, and life circumstances. Basal insulin should not be omitted, including during illness; adjust doses with the person’s care team.
  • Technology: Offer CGM and discuss automated insulin delivery (AID) when appropriate and accessible. Device selection should reflect the person’s abilities, preferences, support, and training—not technology alone. [1]
  • Education and follow-up: Provide structured training in insulin use, carbohydrate estimation, glucose interpretation, sick-day management, and hypoglycemia treatment. Individualize glycemic goals and screen for diabetes complications and associated autoimmune conditions as clinically appropriate. [1]

Safety priorities

Teach recognition and treatment of hypoglycemia and ensure access to glucagon when indicated. During illness or unexplained hyperglycemia, check ketones when advised by the care plan, maintain fluids, and seek urgent assessment for vomiting, abdominal pain, deep or rapid breathing, confusion, or inability to keep fluids down—these may indicate DKA. Suspected DKA requires emergency evaluation. [1]

Sources

[1] https://professional.diabetes.org/standards-of-care American Diabetes Association. Standards of Care in Diabetes—2026. Official guideline hub: [1]
[2] https://www.ispad.org/resources/ispad-clinical-practice-consensus-guidelines/2024-cpcg.html International Society for Pediatric and Adolescent Diabetes. Clinical Practice Consensus Guidelines 2024. [1]

  1. https://www.ispad.org/resources/ispad-clinical-practice-consensus-guidelines.html
  2. https://diabetes.org/newsroom/press-releases/american-diabetes-association-releases-standards-care-diabetes-2026
  3. https://diabetes.org/sites/default/files/2025-12/2026%20Standards%20of%20Care%20press%20release.pdf
  4. https://www.ispad.org/resources/ispad-clinical-practice-consensus-guidelines/2018-ispad-clinical-consensus-guidelines-/2018-clinical-practice-consensus-guidelines.html
  5. https://professional.diabetes.org/
  6. https://pubmed.ncbi.nlm.nih.gov/39662065/
  7. https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/49/supplement_1/11/toc.pdf?Expires=1794820472&Signature=D9oQHaOWv18inCcltYuEhLzW2NaYeHw7CtsxOszBhqXbw7Jqvp8sWFYFTl-ssCdAyL2jFsTmuk-UCcw9c3NaozGnMbbP1GzH03ZDH12lrwAl9FI3dQZ1yaEAzcJZ9eLNORJiVfZnRnAxPgj3KidkXHqQkFAEIba8Eweyu0EAED0Lc0HskL3Li3lUXRMrFnXO7lqSENszW4QBjw466~XdsC2h5iReVDYrh4ASffo3kSDJeeNXIXY~PMdvAppoyRbKryi0bL14aHIYkoAfZxI6dBq13zbPZl~tKw32kpLURieSKcmnWt03SUISJKxQHJxkiymFYdH5uYKTpF4T1ZejiA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA
  8. https://bestpractice.bmj.com/topics/en-us/25
  9. https://www.ispad.org/resources/ispad-clinical-practice-consensus-guidelines/2022-ispad-clinical-practice-consensus-guidelines/ispad-cpcg-2022-english.html
  10. https://accedacris.ulpgc.es/handle/10553/136274?locale=en
  11. https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/49/supplement_1/5/toc.pdf?Expires=1768383299&Signature=0eGPvrFu-EfJU1bnHkpyJSffIjXtGC~Ioi~jvnX73ngN4PuJvOCH1vW~uxLtB0a2e8RN9cm58~9xKXME8QJnqtk4SdRQl60a-yM9Pn2V2zt~BIM4oVDP2O6GhBJIqAk8sLSJk~MyG3rEBvnG0-hVEZZtZ~CSQlsrRdxsCi0Jvf3WxPaOlVYO9h-cuEpkcE-ScvPzU37Ksw4QXWHJMIAOGCTlSp2A7vvFki-Uy9e8i7bI9KEJ-8I5b5QAQ32HH2jT70wZ0bSxSD4GN~lqrFQxsMV~VcbW22UcDY-lsW4KdWy3i36DxlKk4chzfmc7QTRqFgMCtD5JBQnflodmr8QWag__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA
  12. https://reference.medscape.com/cc2/p10/guideline-essentials-2025-american-diabetes-association-2025a100074f
  13. https://www.adameetingnews.org/glp-1-ra-use-technology-unique-needs-of-individuals-are-recurring-themes-in-the-latest-updates-to-the-standards-of-care-in-diabetes/

AI-generated answer based on the cited sources. Check the sources before applying it.

Have a question about your own case? Itaca answers with sources in seconds.

Ask a question